« Return to News | CROs/Service Providers

Cmed relocates to larger office in North Carolina

Monday, November 19, 2012 11:41 AM

Cmed, a clinical trials services and advanced software provider, has relocated its North Carolina office to new, larger premises in Creekstone Park, Durham, N.C.. The new 7,700 square foot facility has almost 50% more space than the former office and represents a considerable asset in the drive for the company's growth.

Located near Research Triangle Park, the new office has a welcoming reception area, expanded meeting space ideal for client meetings, open plan office space and individual offices. Also provided are guest desks and workstations for visitors and mobile staff.

"This move not only gives our teams extra space to work it also positions us nicely for future growth," said Mac McElroy, CEO, U.S. operations, Cmed. "As we continue to see steady growth the new North Carolina office provides ample space to further expand our global operations. Cmed team members have commented that the environment is professional, spacious and comfortable. It feels like where we are supposed to be."

The move to larger facilities represents Cmed's second U.S. office expansion in as many years. In 2011, the company's office in New Providence, N.J., moved to more spacious and functional office space.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.